Longitudinal data analysis examines repeated measurements tracking changes over time. Linear mixed models account for individual variation and temporal correlation. Time-dependent covariates incorporate changing risk factors. Latent growth curve modelling estimates trajectory parameters. Dropout handling prevents bias from missing data.
Regulatory submissions employ longitudinal analysis demonstrating durability. Clinical utility assessment confirms longitudinal endpoint validity. Quality assurance verifies data collection completeness. Statistical sophistication improves analysis appropriateness. Post-approval monitoring employs longitudinal surveillance.
General Biopharmaceutical Concepts
Longitudinal Data Analysis
Longitudinal data analysis evaluates repeated measurements collected over time to identify trends, treatment effects and changes within study populations.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →